We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bespak | LSE:BPK | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 667.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:2161F Bespak PLC 05 October 2007 ADOPTION OF NEW NAME FOR BESPAK PLC With effect from 3rd October, Bespak, a leader in medical devices for inhaled drug delivery and anaesthesia has changed its name from Bespak plc to Consort Medical plc. The Company announced its plan to change its name earlier this year and gained shareholder approval for the change at its Annual General Meeting at the end of September. As the name change applies only to the Company, the familiar Bespak & King Systems brands will continue to exist in their respective market segments. The Bespak brand name will be retained in the Inhaled Drug Delivery business segment which designs and manufactures metered-dose and dry powder inhalers. The King Systems brand, recognised widely in the US, will remain for the division that designs and manufactures breathing circuits, masks and laryngeal tubes. Commenting on the name change, Mark Throdahl, Consort Medical's Chief Executive, said: "During recent years the group has grown in both size and focus to become a leading provider of medical devices. The name 'Consort Medical' conveys our belief that partnerships with customers, whether they be pharmaceutical companies or physicians, are critical to our continued success." ENDS For further information please contact: Consort Medical Mark Throdahl, Chief Executive Tel: +44 (0)1908 552600 Jonathan Glenn, Group Finance Director Maitland Brian Hudspith or Liz Morley Tel: +44 (0)20 7379 5151 Notes for Editors About Consort Medical plc Consort Medical plc is a leader in devices for inhaled drug delivery and anaesthesia. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals. Consort Medical's companies develop and manufacture metered dose inhaler valves, actuators, compliance-aids, dry powder devices, disposable face masks, breathing circuits and laryngeal tubes. The Group has facilities in King's Lynn and Milton Keynes in the UK, Indianapolis, Indiana and Kent, Ohio in the US, and Mumbai, India. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: BPK). For more information, please visit www.consortmedical.com This information is provided by RNS The company news service from the London Stock Exchange END CANIIFEAILLEIID
1 Year Bespak Chart |
1 Month Bespak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions